PTMAP15

Across TCGA pan-cancer cohorts, PTMAP15 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated PTMAP15 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher PTMAP15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PTMAP15 expression acts as an unfavorable survival marker, although some lineages such as OV and KIRP show a favorable association.

KIRC, THCA, and LUSC are the cancer types where PTMAP15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.527	0.662	<.001	114	view →
THCA	DFS	Tertile	IV	0.284	0.728	<.001	72	view →
LUSC	OS	Tertile	III,IV	0.148	0.833	<.001	63	view →
KICH	OS	Tertile	II,III,IV	0.587	0.976	<.001	51	view →
ACC	DFS	Tertile	II,III,IV	0.304	0.693	<.001	48	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
STAD	DFS	Tertile	III,IV	0.205	0.497	.012	24	view →
PAAD	DFS	Tertile	II,III,IV	0.229	0.472	<.001	18	view →
OV	DFS	Tertile	III,IV	0.455	0.354	.034	18	view →
LIHC	DFS	Tertile	All	0.182	0.546	<.001	18	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	12	view →
KIRP	DFS	Tertile	All	0.961	0.836	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

PTMAP15–KIRC (OS)

Open the KIRC breakdown →